What is the Knight ADRC Clinical Trials Unit?
The Washington University School of Medicine Knight Alzheimer Disease Research Center – Clinical Trials Unit (ADRC-CTU) is collaborating with the Global Alzheimer’s Platform Foundation (GAP-Net) and over 100 clinical research partners around the world to expedite Alzheimer treatments, reduce trial costs and durations, and promote diversity in clinical studies. By participating, you contribute to the fight against Alzheimer’s and shape the future of medicine to ensure that no one is left behind.
Trials Unit by the Numbers:
- 35 years of experience
- >100 clinical trials
- >5,400 participants
Alzheimer’s in Missouri:
- 1 in 8 people over age 65
- 122,300 people currently
- ~140,000 people by 2030
Interested in Participating?
If you are interested in learning more about clinical trials studying investigational medicines to delay or slow the progression of Alzheimer’s disease, click the button below to learn more!
The Knight ADRC Clinical Trials Unit works with our amazing research volunteers to conduct clinical trials for the most promising new drugs for the treatment of Alzheimer disease and other dementias. Together, we are moving towards a world without Alzheimer disease and other dementias.
Joy Snider, MD, PhD, Professor of Neurology
Director of the Knight ADRC Clinical Trials Unit